An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.
Drug development is both increasing in cost whilst decreasing in productivity. There is a general acceptance that the current paradigm of R&D needs to change. One alternative approach is drug repositioning. With target-based approaches utilised heavily in the field of drug discovery, it becomes...
Saved in:
| Main Authors: | Joseph Mullen, Simon J Cockell, Peter Woollard, Anil Wipat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155811&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genome-wide association study −Driven drug repositioning for the treatment of insomnia
by: Rahmat Dani Satria, et al.
Published: (2025-06-01) -
Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning
by: Yangyang Wang, et al.
Published: (2025-05-01) -
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies
by: Annamaria Salvati, et al.
Published: (2025-07-01) -
Research on drug repositioning based on generative AI
by: GONG Houwu, et al.
Published: (2025-03-01) -
Improving drug repositioning with negative data labeling using large language models
by: Milan Picard, et al.
Published: (2025-02-01)